The phrase "adherence risk" is correct and usable in written English.
It can be used in contexts related to compliance, particularly in healthcare or regulatory environments, where it refers to the risk associated with not following prescribed guidelines or protocols.
Example: "The study highlighted the adherence risk among patients who frequently missed their medication doses."
Alternatives: "compliance risk" or "non-adherence risk".
Among the factors that influence medication adherence risk are job and home stability.
We also assessed baseline adherence, risk, and health measures.Complicated depressive illness was common.
The presence of ≥2 STLEs was associated with a mean change in adherence of -3.67% (95% confidence interval (CI): -7.12%, -0.21%) and decreased likelihood of achieving ≥95% adherence (risk ratio (95% CI) = 0.82 (0.95, 0.95)).
The aim of this study was to develop a new questionnaire to assess adherence risk factors in topical treatment.
Thus, outcome measures were collected at baseline and again at six months, including health status, treatment adherence, risk behaviors, and quality of life.
The Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) was developed as a pilot project to address this evidence gap.
The lack of change in adherence is perhaps not surprising given the high baseline adherence, risking a ceiling effect, and the low fidelity of intervention delivery achieved.
Composite variable levels representing the highest number of self-management non-adherence risk factors were associated with higher SBP and DBP.
An accurate and sensitive measure of adherence should give clinicians objective data to use during discussions on individuals' non-adherence risk factors without causing shame or stigma to a patient [ 27].
If there are factors that are found to be common across these IMIDs, this will afford the opportunity to develop cross-condition tools for the health care professional (HCP) both to identify areas of non-adherence risk and for generic interventions, which may be particularly useful for rheumatologists who are likely to treat patients with different manifestations of their IMIDs.
Banks can begin using compensation as a tool for change by reviewing adherence to risk limits or procedures as part of employee performance reviews, both to incentivize sound risk taking and to disincentivize misconduct.
